MedPath

Indiana University Foundation, Inc.

Indiana University Foundation, Inc. logo
🇺🇸United States
Ownership
Private
Established
1820-01-20
Employees
10K
Market Cap
-
Website
http://www.indiana.edu

Single-shot TAP Block vs Continuous TAP Block

Phase 4
Completed
Conditions
Postoperative Pain
Interventions
Drug: TAP-S
Device: TAP-C
First Posted Date
2015-06-18
Last Posted Date
2020-08-04
Lead Sponsor
Indiana University
Target Recruit Count
70
Registration Number
NCT02475031
Locations
🇺🇸

Indiana University Hospital, Indianapolis, Indiana, United States

eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

Phase 2
Completed
Conditions
Depression
Depressive Symptoms
Heart Diseases
Coronary Artery Disease
Stroke
Major Depressive Disorder
Dysthymic Disorder
Cardiovascular Diseases
Interventions
Behavioral: Beating the Blues (BtB)
Other: Usual Care
Behavioral: Problem Solving Treatment in Primary Care (PST-PC)
Drug: Antidepressant Medications
First Posted Date
2015-06-01
Last Posted Date
2023-10-19
Lead Sponsor
Indiana University
Target Recruit Count
216
Registration Number
NCT02458690
Locations
🇺🇸

IUPUI Department of Psychology, Indianapolis, Indiana, United States

Prevention of Severe Postpartum Hypertension

Phase 2
Withdrawn
Conditions
Hypertension
Interventions
Drug: Placebo #1
Drug: Furosemide
Drug: Placebo #2
Drug: Potassium chloride
First Posted Date
2015-05-21
Last Posted Date
2023-05-11
Lead Sponsor
Indiana University
Registration Number
NCT02450773
Locations
🇺🇸

Indiana University School of Medicine, Indianapolis, Indiana, United States

🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Low Dose IV Dexamethasone in Prolonging Caudal Anesthesia in Children Undergoing Genitourinary Surgery

Phase 4
Terminated
Conditions
Surgery
Interventions
First Posted Date
2015-05-06
Last Posted Date
2021-05-07
Lead Sponsor
Indiana University
Target Recruit Count
8
Registration Number
NCT02436265
Locations
🇺🇸

Riley Hospital for Children, Indianapolis, Indiana, United States

Molecular Genetics of Heterotaxy and Related Congenital Heart Defects

Recruiting
Conditions
Congenital Heart Defects
Heterotaxy Syndrome
First Posted Date
2015-05-01
Last Posted Date
2024-02-07
Lead Sponsor
Indiana University
Target Recruit Count
2000
Registration Number
NCT02432079
Locations
🇺🇸

Indiana University School of Medicine, Indianapolis, Indiana, United States

Illness Management and Recovery Treatment Integrity Scale Validation and Leadership Intervention Development

Completed
Conditions
Severe Mental Illness
First Posted Date
2015-05-01
Last Posted Date
2015-12-23
Lead Sponsor
Indiana University
Target Recruit Count
299
Registration Number
NCT02431299

Pediatric Cardiomyopathy Mutation Analysis

Recruiting
Conditions
Hypertrophic Cardiomyopathy
Restrictive Cardiomyopathy
Arrhythmogenic Right Ventricular Cardiomyopathy
Cardiomyopathies
Dilated Cardiomyopathy
Left Ventricular Non-compaction Cardiomyopathy
First Posted Date
2015-05-01
Last Posted Date
2024-02-07
Lead Sponsor
Indiana University
Target Recruit Count
300
Registration Number
NCT02432092
Locations
🇺🇸

IU School of Medicine, Indianapolis, Indiana, United States

Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders

Phase 1
Withdrawn
Conditions
Osteoporosis
Glucocorticoid-induced Osteoporosis
Juvenile Rheumatoid Arthritis
Dermatomyositis
Polyarthritis
Vasculitis
Systemic Lupus Erythematosis
Interventions
First Posted Date
2015-04-16
Last Posted Date
2019-12-06
Lead Sponsor
Indiana University
Registration Number
NCT02418273
Locations
🇺🇸

Indiana University School of Medicine, Indianapolis, Indiana, United States

A Trial to Assess Optimal Postoperative Feeding Regiments Following Pyloromyotomy

Not Applicable
Completed
Conditions
Postoperative Feeding Following Pyloromyotomy
Interventions
Other: Incremental Feeds
Other: Ad lib feeds
First Posted Date
2015-04-14
Last Posted Date
2016-05-13
Lead Sponsor
Indiana University
Target Recruit Count
163
Registration Number
NCT02415049
Locations
🇺🇸

Riley Hospital for Children, Indianapolis, Indiana, United States

Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator

Not Applicable
Terminated
Conditions
Inflammatory Bowel Disease
Ulcerative Colitis
Crohn's Disease
Interventions
First Posted Date
2015-04-09
Last Posted Date
2019-11-04
Lead Sponsor
Indiana University
Target Recruit Count
3
Registration Number
NCT02413047
Locations
🇺🇸

Indiana University Hospital, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath